Johnson & Johnsons one-shot Covid-19 vaccine is expected to go into use here shortly after the European Medicines Agency (EMA) this week confirmed that its benefits outweigh any risk of a very rare side effect of abnormal blood clots. Minister for Health Stephen Donnelly has said it will be early next week before the National Immunisation Advisory Committee (Niac) issues recommendations on its deployment.But with people needing only one dose, it could significantly accelerate the vaccine rollout Continue reading →

Drinking a certain root vegetable juice promotes a mix of mouth bacteria associated with healthier blood vessels and brain function, according to a new study of people aged 70-80. Certain foods including lettuce, spinach, and celery are rich in inorganic nitrate, and many oral bacteria play a role in turning nitrate to nitric oxide, which helps to regulate blood vessels and neurotransmission, or chemical messages in the brain. Older people tend to have lower nitric oxide production, and this is associated with poorer vascular (blood vessel) and cognitive (brain) health Continue reading →

Much like weve seen with COVID-19, were calling for the global mobilization of researchers, clinicians, industry leaders and policymakers to accelerate discovery, translation and impact in CVD medicine Professor Figtree Professor Gemma Figtreefrom the University of Sydney,Professor Rebecca Ritchiefrom the Monash Institute of Pharmaceutical Sciences (MIPS) and La Trobe University'sProfessor Grant Drummondwho leads the La Trobe Centre for Cardiovascular Biology and Disease Research, have led the call to action through their shared affiliation with theAustralian Cardiovascular Alliance (ACvA)- Australias peak leadership body for the advancement of heart, stroke and vascular disease research. University of Sydney andKolling Institute's Professor Figtree, who is also President of the ACvA, said: As we continue to wrestle with the immense challenge of implementing equitable access to established evidence-based treatments for CVD, substantial gaps remain - particularly in low- and middle-income countries Continue reading →

The Uveitis Treatment Market report tabled by PersistenceMarketResearch focuses on the parameters of the 4th industrial revolution, which includes technology-driven healthcare solutions, with several breakthroughs in this regard. The entire supply chain right from diagnostics to the delivery of medicines, is being driven by the technological advancements in healthcare Continue reading →

The Molecular Grade Plates Market report tabled by PersistenceMarketResearch focuses on the parameters of the 4th industrial revolution, which includes technology-driven healthcare solutions, with several breakthroughs in this regard. The entire supply chain right from diagnostics to the delivery of medicines, is being driven by the technological advancements in healthcare Continue reading →

The company gained exclusive global rights to the drug for 1 million (A$1.6 million) upfront, 308 million (A$480 million) in milestones and a tiered single-digit royalty on sales. () () recently announced an agreement with Evotec SE (FRA:EVT) to in-license the global rights to EVT801, a novel inhibitor of vascular endothelial growth factor receptor 3 (VEGFR3). Off the back of the deal, HCWainwright & Coanalysts Sean Lee, Swayampakula Ramakanth, Arthur He, Sean Kang have maintained the companys BUY rating and 12-month price target of US$17.00 per ADS Continue reading →